TimesSquare Capital Management, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q1 2018. The put-call ratio across all filers is 3.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
TimesSquare Capital Management, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$67,549,000
+4.5%
392,500
-23.8%
0.59%
+11.5%
Q2 2021$64,627,000
-28.6%
514,995
-22.8%
0.53%
-31.7%
Q1 2021$90,453,000
-10.3%
667,010
-15.3%
0.78%
-5.4%
Q4 2020$100,811,000
+5.2%
787,955
-7.5%
0.82%
-8.7%
Q3 2020$95,859,000
+3.0%
851,855
-12.8%
0.90%
+1.1%
Q2 2020$93,024,000
+3.6%
976,420
-2.3%
0.89%
-17.2%
Q1 2020$89,809,000
+50.5%
999,320
-11.2%
1.07%
+101.3%
Q4 2019$59,678,000
+44.0%
1,125,575
+7.3%
0.53%
+45.0%
Q3 2019$41,442,000
+10.0%
1,048,900
+14.4%
0.37%
+26.6%
Q2 2019$37,669,000
-12.1%
916,970
-0.4%
0.29%
-12.1%
Q1 2019$42,878,000
+38.5%
920,715
+29.5%
0.33%
+23.6%
Q4 2018$30,956,000
-26.7%
710,815
-3.7%
0.27%
-4.6%
Q3 2018$42,242,000
+131.1%
738,115
+96.0%
0.28%
+129.5%
Q2 2018$18,275,000
+40.8%
376,655
+13.4%
0.12%
+38.6%
Q1 2018$12,981,000332,0050.09%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders